Chinese smartwatch manufacturer Lemtofit has launched the affordable Lem 3 smartwatch for the global market. The new Lemtofit Lem 3 smartwatch is said to have received the China Food and Drug Administration (CFDA) certification for its ECG function. This means that the smartwatch can be used as an ECG tool.
Features
The Lem 3 is a relatively affordable wearable that was recently announced by Lemtofit. It comes with a bouquet of health monitoring features seemingly signposted by its ECG functionality. Other health tracking features present in the Lem 3 are blood glucose (non-invasive), blood oxygen, heart rate, and body temperature monitoring.
The smartwatch packs a 1.92-inch display, supports Bluetooth calling and various sports modes are available to the user. The smartwatch can also be controlled using its voice assistant. The watch has up to 7 days of runtime on a single charge and typical usage.
Although Lemtofit has stated that the Lem 3 has the CFDA certification for its ECG measuring tool, it has yet to state the details of the certification. This implies that the accuracy of ECG measurements by the smartwatch has not been established. The Lem 3 will also need to be certified by the National Medical Product Administration (NMPA), which replaced the CFDA in 2018. Non-invasive blood glucose measurements are seen as unreliable, as the US Food and Drug Administration (FDA) released a statement that advised against using smartwatches and smart rings to take blood glucose measurements.
Pricing
The Lem 3 has a retail price of $159.99 but can be purchased directly from Lemtofit at a discounted price of $49.99. The impressive collection of health and fitness features present in the smartwatch, coupled with its very cheap price, could spur demand for the Lem 3.
RELATED:
